TOLUCOMBI

This brand name is authorized in Austria, Germany, Estonia, Spain, Finland, Croatia, Ireland, Italy, Lithuania, Poland, Romania, Singapore, United Kingdom

Active ingredients

The drug TOLUCOMBI contains a combination of these active pharmaceutical ingredients (APIs):

1 Telmisartan UNII U5SYW473RQ - TELMISARTAN

Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting. Read about Telmisartan

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TOLUCOMBI 80 mg/25 mg Tablet	European Medicines Agency (EU)	MPI, EU: SmPC
TOLUCOMBI 40mg/12.5mg / 80mg/12.5mg Tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA07	Telmisartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 10299885, 10299891, 10299916, 10299922, 10299939, 10299945, 10299974, 10299980, 10299997
Country: EE	Ravimiamet	Identifier(s): 1609589, 1609590, 1609602, 1609613, 1609624, 1609635, 1609646, 1609657, 1609668, 1609679, 1609680, 1609691, 1609703, 1609714, 1609725, 1609736, 1609747, 1609758, 1609769, 1609770, 1609781, 1609792, 1609804, 1609815, 1664726, 1664737, 1664748
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 113821004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 381868, 391984, 428658, 476392, 484388, 515151
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 245733, 245735, 245737
Country: IE	Health Products Regulatory Authority	Identifier(s): 61075, 61132, 61453
Country: IT	Agenzia del Farmaco	Identifier(s): 042715045, 042715146, 042715247
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1069357, 1069745, 1069746, 1069747, 1069748, 1069749, 1069750, 1069751, 1069752, 1069753, 1069754, 1069755, 1069756, 1069757, 1069758, 1069759, 1069760, 1069761, 1069762, 1069763, 1069764, 1069765, 1069766, 1069767, 1069768, 1069769, 1069770, 1069771, 1069772, 1069773, 1076140, 1076141, 1076142
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100295015, 100295050, 100295067
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W59819001, W59819002, W59819003, W59819004, W59819005, W59819006, W59819007, W59819008, W59819009, W59819010
Country: SG	Health Sciences Authority	Identifier(s): 15616P, 15617P